文献速递脑血管病外科神经重症

倾向校正分析:超早期治疗动脉瘤性蛛网膜下腔出血与患者结局

Propensity-adjusted analysis of ultra-early aneurysmal subarachnoid hemorrhage treatment and patient outcomes.
PubMed 文献 · Acta Neurochir (Wien) · 2023-01-27

单中心队列纳入2014年1月1日至2019年7月31日期间接受确定性手术或血管内治疗的1013例aSAH患者,其中94例(9%)在破裂后24小时内接受超早期治疗,经倾向校正后超早期治疗与神经功能结局(OR=0.86)、迟发性脑缺血(OR=0.87)及住院时间(exp(β)=0.13)均无显著关联(P≥0.60)。

要点

  • 超早期治疗组动脉瘤破裂后24小时内接受确定性治疗,仅占全部患者的9%。
  • 超早期组囊状动脉瘤比例更低(56% vs 81%),开放手术比例更高(77% vs 57%),男性更多(40% vs 30%)。
  • 倾向校正后超早期治疗与神经功能结局、迟发性脑缺血及住院时间均无显著关联。

核心结论

  • 在大型单中心aSAH队列中,超早期治疗与更好的神经功能结局、更少的迟发性脑缺血或更短的住院时间均无关联。

研究设计与样本

  • 单中心队列研究,纳入2014年1月1日至2019年7月31日期间接受确定性开放手术或血管内治疗的aSAH患者1013例。
  • 超早期治疗定义为动脉瘤破裂后24小时内接受治疗。
  • 主要结局为不良神经功能结局(改良Rankin量表评分>2)。
  • 对年龄、性别、Charlson合并症指数、Hunt和Hess分级、Fisher分级、动脉瘤治疗类型、动脉瘤类型、大小及前循环位置进行倾向校正。

主要发现

  • 1013例患者平均(SD)年龄56(14)岁,女性702例(69%),男性311例(31%);94例(9%)接受超早期治疗。
  • 与非超早期队列相比,超早期治疗队列囊状动脉瘤比例更低(53/94[56%] vs 746/919[81%],P<0.001),开放手术治疗频率更高(72/94[77%] vs 523/919[57%],P<0.001),男性比例更高(38/94[40%] vs 273/919[30%],P=0.04)。
  • 校正后,在至少180天随访的患者中,超早期治疗与神经功能结局无关联(OR=0.86),与迟发性脑缺血发生无关联(OR=0.87),与住院时间无关联(exp(β)=0.13)(P≥0.60)。

关键数值与推荐

  • 超早期治疗定义:动脉瘤破裂后24小时内接受确定性治疗。
  • 不良神经功能结局定义:改良Rankin量表评分>2。
  • 倾向校正变量:年龄、性别、Charlson合并症指数、Hunt和Hess分级、Fisher分级、动脉瘤治疗类型、动脉瘤类型、大小及前循环位置。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optimal definitive treatment timing for patients with aneurysmal subarachnoid hemorrhage (aSAH) remains controversial. We compared outcomes for aSAH patients with ultra-early treatment versus later treatment at a single large center. METHOD: Patients who received definitive open surgical or endovascular treatment for aSAH between January 1, 2014, and July 31, 2019, were included. Ultra-early treatment was defined as occurring within 24 h from aneurysm rupture. The primary outcome was poor neurologic outcome (modified Rankin Scale score > 2). Propensity adjustment was performed for age, sex, Charlson Comorbidity Index, Hunt and Hess grade, Fisher grade, aneurysm treatment type, aneurysm type, size, and anterior location. RESULTS: Of the 1013 patients (mean [SD] age, 56 [14] years; 702 [69%] women, 311 [31%] men) included, 94 (9%) had ultra-early treatment. Compared with the non-ultra-early cohort, the ultra-early treatment cohort had a significantly lower percentage of saccular aneurysms (53 of 94 [56%] vs 746 of 919 [81%], P <0 .001), greater frequency of open surgical treatment (72 of 94 [77%] vs 523 of 919 [57%], P <0 .001), and greater percentage of men (38 of 94 [40%] vs 273 of 919 [30%], P = .04). After adjustment, ultra-early treatment was not associated with neurologic outcome in those with at least 180-day follow-up (OR = 0.86), the occurrence of delayed cerebral ischemia (OR = 0.87), or length of stay (exp(β), 0.13) (P ≥ 0.60). CONCLUSIONS: In a large, single-center cohort of aSAH patients, ultra-early treatment was not associated with better neurologic outcome, fewer cases of delayed cerebral ischemia, or shorter length of stay.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Koester SW, Catapano JS, Rhodenhiser EG, et al. Propensity-adjusted analysis of ultra-early aneurysmal subarachnoid hemorrhage treatment and patient outcomes. Acta Neurochir (Wien). 2023. PMID: 36702969. doi:10.1007/s00701-023-05497-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。